2014
DOI: 10.1016/j.ejmech.2014.09.048
|View full text |Cite
|
Sign up to set email alerts
|

Beta and gamma carboline derivatives as potential anti-Alzheimer agents: A comparison

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
32
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 75 publications
(36 citation statements)
references
References 29 publications
1
32
0
Order By: Relevance
“…β-carbolines and γ-carbolines came into attention of anti-neurodegenerative drug designers due to the assorted activities of harmala alkaloids (harmaline, harmine, harmane, etc. ), which are β-carbolines, as well as by introducing the synthetic compounds with γ-carboline scaffold in pre-clinical and clinical research: dimebon (latrepirdine), karbidine, stobadine, flutroline [13,14,15]. As an indole scaffold occurs in the structure of known TRIs, such as (3a,7a)-3a-(3,4-dichlorophenyl)-2-methyloctahydro-1 H -isoindole and (3aS,6aR)-3a-(3,4-dichlorophenyl)-2-methyloctahydrocyclopenta[c]pyrrole [16], we decided to test antidepressant-like properties based on 5-HT, norepinephrine, and dopamine reuptake inhibition.…”
Section: Introductionmentioning
confidence: 99%
“…β-carbolines and γ-carbolines came into attention of anti-neurodegenerative drug designers due to the assorted activities of harmala alkaloids (harmaline, harmine, harmane, etc. ), which are β-carbolines, as well as by introducing the synthetic compounds with γ-carboline scaffold in pre-clinical and clinical research: dimebon (latrepirdine), karbidine, stobadine, flutroline [13,14,15]. As an indole scaffold occurs in the structure of known TRIs, such as (3a,7a)-3a-(3,4-dichlorophenyl)-2-methyloctahydro-1 H -isoindole and (3aS,6aR)-3a-(3,4-dichlorophenyl)-2-methyloctahydrocyclopenta[c]pyrrole [16], we decided to test antidepressant-like properties based on 5-HT, norepinephrine, and dopamine reuptake inhibition.…”
Section: Introductionmentioning
confidence: 99%
“…The two pathological hallmarks of AD include senile plaques consisting beta-amyloid peptides and neurofibrillary tangles formed by hyperphosphorylation and abnormal deposition of tau proteins [2]. Multifactorial causes require multi-targeted treatment concepts [3]. AD is associated with an impairment of daily activities, behavior disturbances, and a variety of neuropsychiatric symptoms [4].…”
Section: Introductionmentioning
confidence: 99%
“…Specifically, we cannot rule out the possibility that the actual used drugs against AD or PD can be recognized as substrates of brain GSTs or at least inducers of GSH-related enzymes via Kelch-like ECH-associated protein 1/nuclear factorerythroid 2 p45-related factor 2 (Keap1/Nrf2) pathways (Higgins and Hayes, 2011). A large number of putative drugs or drugmolecular targets are cited in the recent literature including nitric oxide synthase (NOS) inhibitors (Maher et al, 2014), pyruvate (Isopi et al, 2014), extracellular matrix molecules (Berezin et al, 2014), ginger components (Azam et al, 2014), cholinesterase inhibitors (Otto et al, 2014), anti-inflammatory drugs (Wang et al, 2015), insulin (Sebastião et al, 2014), etc. We should also mention a possible role of certain bio-metals involved in memory enhancement (zinc) or associated with amyloid precursor protein (APP) (copper) in AD (Parker et al, 2012).…”
Section: Cys47 Cys101mentioning
confidence: 99%